Key facts
- This page summarizes Philip D. McLellan's Form 4 filing for QuidelOrtho Corp (QDEL).
- 14 reported transactions and 6 derivative rows are listed below.
- Accepted by SEC: 03 Feb 2026, 19:51.
Philip D. McLellan - 30 Jan 2026 Form 4 Insider Report for QuidelOrtho Corp (QDEL)
- Reporting relationship
- Chief Operations Officer
- Issuer ticker
- QDEL
- Reported as of
- 30 Jan 2026
- Net transaction value
- -$44,206
- SEC form
- 4
- Accepted by SEC
- 03 Feb 2026, 19:51:02 UTC
- Prior SEC filing
- 02 Feb 2026
- Next SEC filing
- 24 Apr 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jennifer Ahn, attorney-in-fact for Philip D. McLellan
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Philip D. McLellan filed Form 4 for QuidelOrtho Corp (QDEL) on 03 Feb 2026.
Change
- Previous filing in this sequence was filed on 02 Feb 2026.
- Current net transaction value: -$44,206.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002045799
Primary reporting owner
McLellan Philip D.
- Relationship
- Chief Operations Officer
- Address
- 9975 SUMMERS RIDGE ROAD, SAN DIEGO
- Signature
- /s/ Jennifer Ahn, attorney-in-fact for Philip D. McLellan
- Signature date
- 03 Feb 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
QDEL
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +1,127
- Change %
- +7%
- Price
- $0.000000
- Shares after
- 17,311
- Date
- 31 Jan 2026
- Ownership
- Direct
- Footnotes
- F1
QDEL
transaction
Common Stock
Tax liability
- Transaction value
- $11,439
- Shares
- -421
- Change %
- -2.4%
- Price
- $27.17
- Shares after
- 16,890
- Date
- 31 Jan 2026
- Ownership
- Direct
- Footnotes
- F2
QDEL
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +847
- Change %
- +5%
- Price
- $0.000000
- Shares after
- 17,737
- Date
- 31 Jan 2026
- Ownership
- Direct
- Footnotes
- F1
QDEL
transaction
Common Stock
Tax liability
- Transaction value
- $8,260
- Shares
- -304
- Change %
- -1.7%
- Price
- $27.17
- Shares after
- 17,433
- Date
- 31 Jan 2026
- Ownership
- Direct
- Footnotes
- F2
QDEL
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +2,009
- Change %
- +12%
- Price
- $0.000000
- Shares after
- 19,442
- Date
- 31 Jan 2026
- Ownership
- Direct
- Footnotes
- F1
QDEL
transaction
Common Stock
Tax liability
- Transaction value
- $18,313
- Shares
- -674
- Change %
- -3.5%
- Price
- $27.17
- Shares after
- 18,768
- Date
- 31 Jan 2026
- Ownership
- Direct
- Footnotes
- F2
QDEL
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +634
- Change %
- +3.4%
- Price
- $0.000000
- Shares after
- 19,402
- Date
- 31 Jan 2026
- Ownership
- Direct
- Footnotes
- F1
QDEL
transaction
Common Stock
Tax liability
- Transaction value
- $6,195
- Shares
- -228
- Change %
- -1.2%
- Price
- $27.17
- Shares after
- 19,174
- Date
- 31 Jan 2026
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
QDEL
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +36,152
- Change %
- Price
- $0.000000
- Shares after
- 36,152
- Date
- 30 Jan 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 36,152
- Exercise price
- Footnotes
- F3, F4
QDEL
transaction
Derivative
Non-Qualified Stock Options
Award
- Transaction value
- $0
- Shares
- +36,150
- Change %
- Price
- $0.000000
- Shares after
- 36,150
- Date
- 30 Jan 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 36,150
- Exercise price
- $27.17
- Footnotes
- F5
QDEL
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -1,127
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 31 Jan 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,127
- Exercise price
- Footnotes
- F3, F6
QDEL
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -847
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 31 Jan 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 847
- Exercise price
- Footnotes
- F3, F7
QDEL
transaction
Derivative
Restricted Stock Units (Converted)
Options Exercise
- Transaction value
- $0
- Shares
- -2,009
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 31 Jan 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,009
- Exercise price
- Footnotes
- F3, F8
QDEL
transaction
Derivative
Restricted Stock Units (Premium )
Options Exercise
- Transaction value
- $0
- Shares
- -634
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 31 Jan 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 634
- Exercise price
- Footnotes
- F3, F8
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 8 footnotes
Footnote F1
Reflects release of restricted stock units that were previously reported on a Form 3 or Form 4.
Footnote F2
Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
Footnote F3
Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
Footnote F4
12,050 shares will vest on January 30, 2027; the remaining 24,102 shares will vest in equal installments on January 30, 2028 and January 30, 2029.
Footnote F5
36,150 shares will vest in equal installments on January 30, 2027, January 30, 2028 and January 30, 2029.
Footnote F6
2,254 shares vested in equal installments on January 31, 2025 and January 31, 2026.
Footnote F7
846 shares vested on January 31, 2025 and 847 shares vested on January 31, 2026.
Footnote F8
Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and occurred according to the elected deferred schedule.